MASETTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.250
EU - Europa 964
AS - Asia 337
AF - Africa 64
SA - Sud America 5
OC - Oceania 1
Totale 2.621
Nazione #
US - Stati Uniti d'America 1.249
GB - Regno Unito 244
SE - Svezia 179
IT - Italia 156
CN - Cina 154
DE - Germania 143
VN - Vietnam 103
IE - Irlanda 52
IN - India 49
UA - Ucraina 49
RU - Federazione Russa 38
FR - Francia 30
TG - Togo 26
JO - Giordania 21
ZA - Sudafrica 21
BG - Bulgaria 19
EE - Estonia 18
BE - Belgio 10
NG - Nigeria 9
FI - Finlandia 8
AT - Austria 7
CI - Costa d'Avorio 6
CH - Svizzera 5
IR - Iran 3
BR - Brasile 2
CL - Cile 2
DK - Danimarca 2
JP - Giappone 2
NL - Olanda 2
SC - Seychelles 2
SG - Singapore 2
AU - Australia 1
CA - Canada 1
CO - Colombia 1
GR - Grecia 1
KR - Corea 1
LB - Libano 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 2.621
Città #
Southend 216
Chandler 163
Fairfield 142
Ashburn 97
Seattle 75
Ann Arbor 65
Houston 65
Princeton 65
Wilmington 65
Woodbridge 59
Cambridge 52
Dong Ket 52
Dublin 52
New York 37
Nanjing 29
Bremen 27
Jacksonville 26
Lomé 26
Redmond 26
Padova 24
Westminster 24
Turin 23
Amman 21
Berlin 20
Bologna 20
Sofia 19
Shenyang 18
Medford 14
Hebei 12
Jinan 11
Beijing 10
Dearborn 10
Mülheim 10
Saint Petersburg 10
Abeokuta 9
Brussels 9
Changsha 9
Helsinki 8
Jiaxing 8
San Diego 8
Boardman 7
Nanchang 7
Redwood City 7
Rome 7
Abidjan 6
Guangzhou 6
Taiyuan 6
Tianjin 6
Vienna 6
Zhengzhou 6
Des Moines 5
Kuban 5
San Venanzo 5
Florence 4
Haikou 4
Kunming 4
Olalla 4
Taizhou 4
Los Angeles 3
Milan 3
Verona 3
Adrara San Martino 2
Bari 2
Den Haag 2
Falls Church 2
Henderson 2
Las Vegas 2
Lausanne 2
Mahé 2
Ningbo 2
Phoenix 2
Acton 1
Adliswil 1
Arica 1
Atlanta 1
Augusta 1
Azzate 1
Baveno 1
Bergamo 1
Bern 1
Boydton 1
Brooklyn 1
Bryanston 1
Casalecchio Di Reno 1
Changchun 1
Chengdu 1
Costa Mesa 1
Easton 1
Faenza 1
Genova 1
Hangzhou 1
Hefei 1
Lanzhou 1
London 1
Maser 1
Moscow 1
Norwalk 1
Orange 1
Plauen 1
Ravenna 1
Totale 1.793
Nome #
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 167
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 142
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 137
Impact of Procedure Volumes and Focused Practice on Short-Term Outcomes of Elective and Urgent Colon Cancer Resection in Italy 125
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 124
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 114
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 111
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 105
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 105
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 101
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 99
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 99
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 97
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 92
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 92
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 91
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 86
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 86
Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. 85
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 84
Prevalence of substance-related disorders in heart transplantation candidates 84
Manifestations of health anxiety in patients with heart transplant 84
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 81
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 79
Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes 71
Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation 65
Predicting hemorrhagic transformation and its timing from maximum cerebral lesion diameter in nonlacunar ischemic strokes 63
Pretransplant Right Ventricular Dysfunction Is Associated With Increased Mortality After Heart Transplantation: A Hard Inheritance to Overcome 16
Longest reported support (7.5 years) with postauricular type of Jarvik 2000 axial-flow left ventricular assist device 12
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 9
Totale 2.706
Categoria #
all - tutte 6.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020646 97 17 9 36 59 72 76 66 102 35 28 49
2020/2021409 81 14 22 20 3 10 43 14 43 13 10 136
2021/2022519 24 22 28 70 50 21 11 32 16 57 102 86
2022/2023692 73 107 40 88 55 55 13 33 127 22 60 19
2023/2024175 13 27 7 23 4 65 5 8 3 10 1 9
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 2.706